Annexin A’s Life in Pan-Cancer: Especially in Glioma Immune Cells
NeuroMolecular Medicine · 26.02.2025 · 27 (1)
DOI: 10.1007/s12017-024-08827-9 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift NeuroMolecular Medicine, online erschienen am 26.02.2025. Verfasst von Yujing Wen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Anhui Province Key Laboratory of Non-Coding RNA Basic and Clinical Transformation (Wannan Medical College), Yijishan Hospital of Wannan Medical Colle…. Hauptthemen laut MEDLINE: Annexin A2, Brain Neoplasms, Glioma, Neoplasm Proteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 46 Literaturangaben.
Abstract (Originalsprache)
The Annexin A (ANXA) family plays a critical role in cancer, with particular emphasis on their prognostic significance in pan-cancer analyses and gliomas. By integrating multi-omics data from The Cancer Genome Atlas (TCGA) and single-cell sequencing analysis, we conducted a comprehensive evaluation of ANXA2 and ANXA4 to investigate their expression patterns and functional impacts across various cancers, with a focus on glioblastoma (GBM). Our analysis encompassed several key components, including literature review, identification of differentially expressed genes (DEGs) in cancer, survival analysis, co-expression studies, competing endogenous RNA networks, cellular functional analysis, tumor microenvironment response to chemotherapy, and tumor stemness. Special attention was given to glioblastoma and low-grade glioma. Notably, our findings highlighted discrepancies among the analytical tools used, underscoring the necessity of employing multiple methods for accurate identification of DEGs. Additionally, we determined that ANXA2 and ANXA4 are predominantly expressed by M2 macrophages in GBM, based on our characterization of human glioma macrophages. These results suggest a strong correlation between ANXA2 and ANXA4 expression levels and the presence of macrophages and CD4 + resting memory T cells in gliomas, offering valuable insights into the complex interplay between the ANXA family and cancer progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Anhui Province Key Laboratory of Non-Coding RNA Basic and Clinical Transformation (Wannan Medical College), Yijishan Hospital of Wannan Medical College, Wuhu, 241000, China.
- Central Laboratory, Yijishan Hospital of Wannan Medical College, Wuhu, 241000, China.
- Yangtze River Delta Information Intelligence Innovation Research Institute, Wuhu, 241000, Anhui, China.
- Anhui Province Key Laboratory of Non-Coding RNA Basic and Clinical Transformation (Wannan Medical College), Yijishan Hospital of Wannan Medical College, Wuhu, 241000, China. lvkun@yjsyy.com.
- Central Laboratory, Yijishan Hospital of Wannan Medical College, Wuhu, 241000, China. lvkun@yjsyy.com.
- Department of Diagnostic and Interventional Radiology, University of Tsukuba, Faculty of Medicine, lbaraki, Tsukuba, Japan. sunferrero@gmail.com.
Zitieren
APA
Wen, Y., Zhou, W., Zhao, Z., Ma, D., Mao, J., Cai, Y., Liu, F., Zhou, J., Lv, K., Gu, W., & Jiang, L. (2025). Annexin A’s Life in Pan-Cancer: Especially in Glioma Immune Cells. NeuroMolecular Medicine, 27(1). https://doi.org/10.1007/s12017-024-08827-9
Vancouver
Wen Y, Zhou W, Zhao Z, Ma D, Mao J, Cai Y, et al. Annexin A’s Life in Pan-Cancer: Especially in Glioma Immune Cells. NeuroMolecular Medicine. 2025;27(1). doi:10.1007/s12017-024-08827-9
BibTeX
@article{Wen2025,
author = {Wen, Yujing and Zhou, Wenhao and Zhao, Zhenzhen and Ma, Didi and Mao, Jian and Cai, Yingjie and Liu, Fugui and Zhou, Juan and Lv, Kun and Gu, Wenchao and Jiang, Lan},
title = {Annexin A’s Life in Pan-Cancer: Especially in Glioma Immune Cells},
journal = {NeuroMolecular Medicine},
year = {2025},
volume = {27},
number = {1},
doi = {10.1007/s12017-024-08827-9}
}
EUVIMED